statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	463
SG - Singapore	188
VN - Vietnam	119
IT - Italia	102
CN - Cina	100
BR - Brasile	51
HK - Hong Kong	51
DE - Germania	35
IE - Irlanda	32
FR - Francia	31
ZA - Sudafrica	25
RU - Federazione Russa	18
AR - Argentina	17
IN - India	16
NL - Olanda	12
SE - Svezia	11
CZ - Repubblica Ceca	9
GB - Regno Unito	9
CA - Canada	8
FI - Finlandia	8
MX - Messico	8
IQ - Iraq	7
BD - Bangladesh	6
KR - Corea	6
CI - Costa d'Avorio	5
EC - Ecuador	5
JP - Giappone	5
MA - Marocco	5
CO - Colombia	4
PK - Pakistan	4
PL - Polonia	4
TR - Turchia	4
AE - Emirati Arabi Uniti	3
AT - Austria	3
PH - Filippine	3
TH - Thailandia	3
VE - Venezuela	3
BE - Belgio	2
CH - Svizzera	2
EG - Egitto	2
ES - Italia	2
ID - Indonesia	2
IR - Iran	2
KG - Kirghizistan	2
MY - Malesia	2
MZ - Mozambico	2
PE - Perù	2
UA - Ucraina	2
BO - Bolivia	1
CL - Cile	1
DZ - Algeria	1
IL - Israele	1
JM - Giamaica	1
KE - Kenya	1
KW - Kuwait	1
KZ - Kazakistan	1
LB - Libano	1
LT - Lituania	1
MN - Mongolia	1
MU - Mauritius	1
NP - Nepal	1
OM - Oman	1
PS - Palestinian Territory	1
PY - Paraguay	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
SY - Repubblica araba siriana	1
TC - Turks e Caicos	1
TJ - Tagikistan	1
Totale	1.426

Nome	#
Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma	161
Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients	151
Activation of G protein-coupled receptors by ketone bodies: Clinical implication of the ketogenic diet in metabolic disorders	140
A personalized molecular approach in multiple myeloma: the possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitors	140
The impact of CD56 expression in smoldering myeloma patients on early progression	134
CD38 expression by plasma cells in extramedullary multiple myeloma	133
SARS-CoV-2 Spike protein is not pro-inflammatory in human primary macrophages: endotoxin contamination and lack of protein glycosylation as possible confounders	126
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response	109
Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma	107
High glutamate levels in the bone marrow of multiple myeloma patients promote osteoclast formation: a novel target for osteolytic bone disease	99
Pygo2 Is Overexpressed in Myeloma Cells With 1q21 Amplification Being Involved in Carfilzomib Resistance	84
Deciphering the bone marrow microenvironment’s role in multiple myeloma immunotherapy resistance	58
Totale	1.442

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	7	0	0	0	0	0	0	0	0	3	0	1	3
2022/2023	80	4	3	0	3	12	2	7	2	33	5	7	2
2023/2024	111	4	3	2	6	7	23	11	4	4	6	12	29
2024/2025	325	10	8	19	36	26	22	20	23	41	32	31	57
2025/2026	919	68	74	161	86	113	70	106	51	127	63	0	0
Totale													1.442